Details for New Drug Application (NDA): 210066
✉ Email this page to a colleague
The generic ingredient in APIXABAN is apixaban. There are thirty drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the apixaban profile page.
Summary for 210066
Tradename: | APIXABAN |
Applicant: | Hetero Labs Ltd V |
Ingredient: | apixaban |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
Approval Date: | Nov 21, 2023 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Nov 21, 2023 | TE: | AB | RLD: | No |
Complete Access Available with Subscription